Siemens' syngo TrueD is designed for oncology, supporting PET/CT, SPECT/CT as well as CT or MR fused with PET or SPECT. The syngo TrueD was de-signed to allow physicians to compare patient scans from different time points (such as pre- and post-therapy) and provide advanced image analysis and comparison.
May 2008
May 15, 2024 — Heart disease is the leading cause of mortality in the U.S., accounting for one out of every five deaths ...
May 15, 2024 
May 15, 2024 — Transfer learning (TL) models trained on heterogeneous public datasets and fine-tuned using institutional ...
May 15, 2024 
May 14, 2024 — University Hospitals (UH) and Siemens Healthineers announce a 10-year strategic alliance that builds on ...
May 14, 2024 
May 13, 2024 — Avenda Health, an AI healthcare company creating the future of personalized prostate cancer care, unveils ...
May 13, 2024 
May 13, 2024 — National Basketball Association (NBA), the National Basketball Players Association (NBPA), and the Next ...
May 13, 2024 
May 8, 2024 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization of ...
May 08, 2024 
May 6, 2024 — Elekta announced the acquisition of Philips Healthcare’s Pinnacle Treatment Planning System (TPS) patent ...
May 06, 2024 
May 2, 2024 — Head and abdominal trauma is a leading cause of death for children. About 1%–2% of children who come to ...
May 02, 2024 
Beginning this spring, ITN will begin sending out a bi-monthly survey to our readers on a variety of topics, which we ...
May 02, 2024 
May 1, 2024 — Sun Nuclear, a Mirion Medical company, today announced the upcoming version 5.0 release of its SunCHECK ...
May 01, 2024